Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) — Normal, Illinois

Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) is a clinical research site located in Normal, Illinois, United States 61761.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Normal

Browse all research sites in Illinois · View every site in Normal

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3)?

Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) conducted?

Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) has 1 clinical trials on record. Their work covers Breast Cancer.

Is Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) accredited by Crixeo Clinical Trials?

Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.